The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Methoxy-5-(4-methyl-5-(4-(piperazin-1-yl)phenyl)pyridin-3-yl)thiophene-2-carboxamide ID: ALA4552750
PubChem CID: 155556360
Max Phase: Preclinical
Molecular Formula: C22H24N4O2S
Molecular Weight: 408.53
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)sc1C(N)=O
Standard InChI: InChI=1S/C22H24N4O2S/c1-14-17(15-3-5-16(6-4-15)26-9-7-24-8-10-26)12-25-13-18(14)20-11-19(28-2)21(29-20)22(23)27/h3-6,11-13,24H,7-10H2,1-2H3,(H2,23,27)
Standard InChI Key: HPZXWEUZOCTISB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
25.3852 -4.9815 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3840 -5.8052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0921 -6.2142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8059 -5.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8030 -4.9779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0903 -4.5685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0979 -7.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3843 -7.4452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3838 -8.2658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0919 -8.6754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8062 -8.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8032 -7.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1005 -9.4940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3874 -9.9063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3863 -10.7241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0967 -11.1357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.8058 -10.7276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.8086 -9.9037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5183 -6.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5103 -4.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2582 -4.8925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8029 -4.2801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3888 -3.5728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5883 -3.7482 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.7166 -2.8242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5287 -2.7338 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2322 -2.1660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6162 -4.3606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9531 -5.1051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
4 19 1 0
5 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 20 1 0
23 25 1 0
25 26 1 0
25 27 2 0
22 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 408.53Molecular Weight (Monoisotopic): 408.1620AlogP: 3.30#Rotatable Bonds: 5Polar Surface Area: 80.48Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.53CX Basic pKa: 8.88CX LogP: 2.74CX LogD: 1.25Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -0.88
References 1. Ensan D, Smil D, Zepeda-Velázquez CA, Panagopoulos D, Wong JF, Williams EP, Adamson R, Bullock AN, Kiyota T, Aman A, Roberts OG, Edwards AM, O'Meara JA, Isaac MB, Al-Awar R.. (2020) Targeting ALK2: An Open Science Approach to Developing Therapeutics for the Treatment of Diffuse Intrinsic Pontine Glioma., 63 (9): [PMID:32369358 ] [10.1021/acs.jmedchem.0c00395 ]